Back    Zoom +    Zoom -
FOSUN PHARMA Self-developed PharmAID Decision Agent Platform Links to Deepseek R1
Recommend
4
Positive
8
Negative
2
FOSUN PHARMA (02196.HK) recently released internally its self-developed PharmAID decision agent platform, which is currently constructing a full lifecycle intelligent decision-making network covering innovative R&D scenarios, according to FOSUN PHARMA.

The platform deeply integrates the world's leading foundation model technology, with AI translation, AI medical writing/ revision and other functions, and has taken the lead in accessing Deepseek R1 and a number of professional clinical information and pipeline data platforms around the world, enabling the accuracy rate of content generation in the medical and healthcare fields to be increased by 50% compared with that of general foundation models, with data updated on a “T+1” basis.

Related NewsJPM Suggests Investors to Buy in Lagging Sectors Like Property/ Biotech During Quarterly Results Period, Trim Holdings in AI Investment Targets

AAStocks Financial News